Management of respiratory symptoms in ALS

Journal of Neurology

Volumn 258, Issue 3, 2011, Pages 359-365

  Hardiman, Orla ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

ALS; Non invasive ventilation; Respiratory function

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OPIATE;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; ATELECTASIS; BLOOD GAS; BREATHING MUSCLE; BULBAR PARALYSIS; CLINICAL FEATURE; CONFUSION; DRUG DOSE TITRATION; FATIGUE; GASTROSTOMY; HUMAN; HYPERMETABOLISM; LIFE EXPECTANCY; LUNG COMPLIANCE; MEDICAL DECISION MAKING; MUSCLE WEAKNESS; NUTRITIONAL DEFICIENCY; OXYGEN SATURATION; PAIN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RESTLESSNESS; REVIEW; SNIFFING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MANAGEMENT; HUMANS; PALLIATIVE CARE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; RESPIRATORY MUSCLES;

EID: 79953785573     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5830-y     Document Type: Review

References (42)

1. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218-1226
2. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, Hauw JJ, Meininger V (2008) Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler 9(1):59-62 (Pubitemid 351260374)
3. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG (2009) Eurals consortium. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10(5-6):310-323
4. Koritnik B, Azam S, Andrew CM, Leigh PN, Williams SC (2009) Imaging the brain during sniffing: a pilot fMRI study. Pulm Pharmacol Ther 22(2):97-101
5. Evans KC, Shea SA, Saykin AJ (1999) Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans. J Physiol 520(Pt 2):383-392 (Pubitemid 29511902)
6. Ramsay SC, Adams L, Murphy K, Corfield DR, Grootoonk S, Bailey DL, Frackowiak RS, Guz A (1993) Regional cerebral blood flow during volitional expiration in man: a comparison with volitional inspiration. J Physiol 461:85-101 (Pubitemid 23104380)
7. Shimizu T, Komori T, Kugio Y, Fujimaki Y, Oyanagi K, Hayashi H (2010) Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1-2):57-62
8. de Carvalho M, Swash M (2010) Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study. Muscle Nerve 41(2):208-211
9. Atalaia A, De Carvalho M, Evangelista T, Pinto A (2007) Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler 8(2):101-105 (Pubitemid 46605396)
10. Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11(4):379-382
11. Phukan J, Pender N, Hardiman O. Cognitive Dysfunction in ALS Lancet Neurology 2007
12. Elman LB, Siderowf A, Houseman G, Kelley M, McCluskey LF (2005) Venous thrombosis in an ALS population over four years. Amyotroph Lateral Scler Other Motor Neuron Disord 6(4):246-249
13. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256(8):1236-1242
14. Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr (1979) Spirometry in amyotrophic lateral sclerosis. Arch Neurol 36:74-80 (Pubitemid 9083183)
15. Czaplinski A, Yen AA, Appel SH (2006) Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 77:390-392
16. Stambler N, Charatan M, Cedarbaum JM (1998) Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 50:66-72 (Pubitemid 28106021)
17. Sanjak M, Salachas F, Frija-Orvoen E, Theys P, Hutchinson D, Verheijde J, Pianta T, Stewart H, Brooks BR, Meininger V, Douillet P (2010) Xaliproden [SR57746A] ALS International Study Group. Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(4):383-388
18. Lanka V, Cudkowicz M (2008) Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler 9(3):131-140 (Pubitemid 351983173)
19. Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson M, Douglas JA, Robinson PJ, McCombe PA (2010) Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1-2):194-202
20. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW (2005) Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 171(3):269-274
21. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J (2001) Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 124:2000-2013 (Pubitemid 32945900)
22. Pinto S, Pinto A, Atalaia A, Peralta R, de Carvalho M (2007) Respiratory apraxia in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8(3):180-184 (Pubitemid 46887917)
23. Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, Myers D, Heberlin L, King R, Smith J, Gelinas D, Miller RG (2001) A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 191(1-2):75-78 (Pubitemid 33035898)
24. Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M (2009) Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol 120(12):2082-2085
25. Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M (2009) Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies. Clin Neurophysiol 120(5):941-946
26. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B (2007) EALSC Working Group. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 8(4):195-213
27. Sancho J, Servera E, Díaz J, Marín J (2004) Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 125(4):1400-1405 (Pubitemid 38501356)
28. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM (1999) A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169(1-2):118-125 (Pubitemid 29502518)
29. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140-147 (Pubitemid 43109171)
30. Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ (2003) Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 61(2):171-177 (Pubitemid 36875296)
31. Radunovic A, Annane D, Jewitt K, Mustfa N (2009) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 7(4):CD004427
32. Pinto S, De Carvalho M (2010) Is a four-hour use of non-invasive ventilation enough to define compliance? Amyotroph Lateral Scler 11(1-2):250-252
33. Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL (2005) Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 32(6):808-811 (Pubitemid 41748278)
34. Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, Kohn MA, Lomen-Hoerth C (2005) The effects of executive and behavioral dysfunction on the course of ALS. Neurology 65(11):1774-1777
35. Onders RP, Elmo M, Khansarinia S, Bowman B, Yee J, Road J, Bass B, Dunkin B, Ingvarsson PE, Oddsdóttir M (2009) Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 23(7):1433-1440
36. Borasio GD, Shaw PJ, Hardiman O, Ludolph AC, Sales Luis ML, Silani V (2001) European ALS Study Group. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord 2(3):159-164
37. Borasio GD, Gelinas DF, Yanagisawa N (1998) Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol 245(Suppl 2):S7-S12 discussion S29
38. Schlamp V, Karg O, Abel A, Schlotter B, Wasner M, Borasio GD (1998) Noninvasive intermittent self-ventilation as a palliative measure in amyotrophic lateral sclerosis. Nervenarzt 69(12): 1074-1082 (Pubitemid 29001153)
39. Neudert C, Oliver D, Wasner M, Borasio GD (2001) The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 248(7):612-616 (Pubitemid 32700299)
40. Meyer T, Dullinger JS, Münch C, Keil JP, Hempel E, Rosseau S, Borisow N, Linke P (2008) Elective termination of respiratory therapy in amyotrophic lateral sclerosis. Nervenarzt 79(6):684-690
41. Borasio GD, Voltz R (1998) Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis. J Neurol 245(11):717-722 (Pubitemid 28468470)
42. Albert SM, Whitaker A, Rabkin JG, del Bene M, Tider T, O'Sullivan I, Mitsumoto H (2009) Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manage 38(4):546-553